BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35782899)

  • 1. Polo-like kinase 4 is associated with advanced TNM stages and reduced survival and its inhibition improves chemosensitivity in colorectal cancer.
    Duan Z; Cai L; Cao J; Wu W
    Oncol Lett; 2022 Aug; 24(2):269. PubMed ID: 35782899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein Kinase D1 Correlates with Less Lymph Node Metastasis Risk, Enhanced 5-FU Sensitivity, and Better Prognosis in Colorectal Cancer.
    Huang B; He Z
    Tohoku J Exp Med; 2023 Aug; 260(4):305-314. PubMed ID: 37225445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polo-Like Kinase 4 Correlates with Aggressive Tumor Characteristics, Shortened Disease-Free Survival and Overall Survival in Patients with Cutaneous Melanoma who Undergo Surgical Resection.
    Zhang L; Zhang S; Han Z; Liu Z; Xu Y; Li X; Miao G; Niu L
    Tohoku J Exp Med; 2024 Apr; 262(4):253-261. PubMed ID: 37940564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant expression of polo-like kinase 4 in renal cell carcinoma: Association with clinicopathological characteristics and long-term survival.
    Jiang W; Zhao Y; Zhang S; Zeng Y; Ma J
    Oncol Lett; 2022 Dec; 24(6):427. PubMed ID: 36311683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polo-like kinase 4 correlates with greater tumor size, lymph node metastasis and confers poor survival in non-small cell lung cancer.
    Zhou Q; Fan G; Dong Y
    J Clin Lab Anal; 2020 Apr; 34(4):e23152. PubMed ID: 31876063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PLK4 is a key molecule in the formation of PGCCs and promotes invasion and migration of progeny cells derived from PGCCs.
    Fu F; Chen L; Yang X; Fan L; Zhang M; Chen S; Zheng M; Gao M; Zhang S
    J Cancer; 2022; 13(9):2954-2969. PubMed ID: 35912011
    [No Abstract]   [Full Text] [Related]  

  • 7. Tumor polo-like kinase 4 protein expression reflects lymphovascular invasion, higher Federation of Gynecology and Obstetrics stage, and shortened survival in endometrial cancer patients who undergo surgical resection.
    Zhao Q; Wang M; Chen M
    BMC Womens Health; 2024 Feb; 24(1):101. PubMed ID: 38326803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High PLK4 expression promotes tumor progression and induces epithelial‑mesenchymal transition by regulating the Wnt/β‑catenin signaling pathway in colorectal cancer.
    Liao Z; Zhang H; Fan P; Huang Q; Dong K; Qi Y; Song J; Chen L; Liang H; Chen X; Zhang Z; Zhang B
    Int J Oncol; 2019 Feb; 54(2):479-490. PubMed ID: 30570110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Corrigendum] LYPD8 regulates the proliferation and migration of colorectal cancer cells through inhibiting the secretion of IL‑6 and TNF‑α.
    Xu J; Qian J; Zhang W; Chen E; Zhang G; Cao G; Wang F; Shen X; Zhou W; Song Z
    Oncol Rep; 2021 May; 45(5):. PubMed ID: 33882644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA GIHCG induces cancer progression and chemoresistance and indicates poor prognosis in colorectal cancer.
    Jiang X; Li Q; Zhang S; Song C; Zheng P
    Onco Targets Ther; 2019; 12():1059-1070. PubMed ID: 30799935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GDPD5, a target of miR-195-5p, is associated with metastasis and chemoresistance in colorectal cancer.
    Feng C; Zhang L; Sun Y; Li X; Zhan L; Lou Y; Wang Y; Liu L; Zhang Y
    Biomed Pharmacother; 2018 May; 101():945-952. PubMed ID: 29635904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of Polo-Like Kinase 4(PLK4) in Breast Cancer and Its Response to Taxane-Based Neoadjuvant Chemotherapy.
    Li Z; Dai K; Wang C; Song Y; Gu F; Liu F; Fu L
    J Cancer; 2016; 7(9):1125-32. PubMed ID: 27326256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of polo-like kinase 4 in hepatocellular carcinoma associates with poor prognosis.
    Liu L; Zhang CZ; Cai M; Fu J; Chen GG; Yun J
    PLoS One; 2012; 7(7):e41293. PubMed ID: 22829937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinoic Acid-Induced 2 (RAI2) Is a Novel Antagonist of Wnt/β-Catenin Signaling Pathway and Potential Biomarker of Chemosensitivity in Colorectal Cancer.
    Zhang W; Kong L; Zhu H; Sun D; Han Q; Yan B; Cui Z; Zhang W; Zhang S; Kang X; Dai G; Qian N; Yan W
    Front Oncol; 2022; 12():805290. PubMed ID: 35299743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autophagy Inhibition Contributes to Apoptosis of PLK4 Downregulation-induced Dormant Cells in Colorectal Cancer.
    Tian X; He Y; Qi L; Liu D; Zhou D; Liu Y; Gong W; Han Z; Xia Y; Li H; Wang J; Zhu K; Chen L; Guo H; Zhao Q
    Int J Biol Sci; 2023; 19(9):2817-2834. PubMed ID: 37324947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of Wnt antagonist sFPR1, Slug and β-catenin with prognosis and metastasis in colorectal carcinoma.
    Wu Q; Zhou L; Yang Y; Qin Y; Ou Y
    Int J Clin Exp Pathol; 2018; 11(1):269-280. PubMed ID: 31938110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and clinical significance of SALL4 and β-catenin in colorectal cancer.
    Hao L; Zhao Y; Wang Z; Yin H; Zhang X; He T; Song S; Sun S; Wang B; Li Z; Su Q
    J Mol Histol; 2016 Apr; 47(2):117-28. PubMed ID: 26779651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circ-0104631 promotes cell proliferation and invasion in colorectal cancer and predicts poor prognosis.
    Cao JZ; Ma LM; Zhang YL; Guo HC; Niu X; Zhao TB
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4730-4737. PubMed ID: 31210299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GOLPH3 predicts survival of colorectal cancer patients treated with 5-fluorouracil-based adjuvant chemotherapy.
    Wang Z; Jiang B; Chen L; Di J; Cui M; Liu M; Ma Y; Yang H; Xing J; Zhang C; Yao Z; Zhang N; Dong B; Ji J; Su X
    J Transl Med; 2014 Jan; 12():15. PubMed ID: 24444035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between mitochondrial TRAP-1 expression and lymph node metastasis in colorectal cancer.
    Gao JY; Song BR; Peng JJ; Lu YM
    World J Gastroenterol; 2012 Nov; 18(41):5965-71. PubMed ID: 23139614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.